UroGen Pharma Ltd —— 现金流量表 (NASDAQ:URGN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -105.89 M-84.89 M-87.56 M-76.38 M-96.77 M-162.44 M -162.44 M 投资活动产生的现金 93.24 M4.07 M1.06 M-953 K-20.61 M61.56 M 61.56 M 融资活动产生的现金 16.53 M72.32 M97.13 M116.93 M194.62 M39.92 M 39.92 M 自由现金流 -107.1 M-85.64 M-87.81 M-76.57 M-97.06 M-162.73 M -162.73 M

新闻

UroGen: ZUSDURI Poised To Replace TURBT Surgery As SOC In Certain Bladder Cancers

UroGen Pharma在TD Cowen会议上展示战略增长与创新

UroGen Pharma at TD Cowen Conference: Strategic Growth and Innovation

Oppenheimer上调UroGen Pharma股票目标价至34美元,看好Zusduri销售表现

Oppenheimer raises UroGen Pharma stock price target to $34 on Zusduri sales

Oppenheimer重申UroGen Pharma股票评级,Zusduri销售强劲

Oppenheimer reiterates UroGen Pharma stock rating on strong Zusduri sales

UroGen Pharma第四季度业绩不及每股收益和营收预期

Earnings call transcript: UroGen Pharma Q4 2025 misses EPS and revenue forecasts

Palantir and AeroVironment among market cap stock movers on Monday

Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates

UroGen PharmaQ1每股收益及营收逊于预期